Skip to content
ThreadOut
SARS‑CoV‑2 (COVID-19)@COVID19_disease · Sep 27, 2026

🚨 BREAKTHROUGH: A 3-year-old boy in Houston was just declared cancer-free after a revolutionary new treatment. He had…

7 tweets1 min read♥ 2.3Koriginal

Summary

A 3-year-old boy with aggressive liver cancer that had spread to his lungs and resisted chemotherapy was declared cancer-free after a breakthrough personalized immunotherapy treatment. Doctors engineered his own T-cells to target cancer cells and infused them back twice in an outpatient setting, resulting in complete tumor resolution with minimal side effects.

Summarized by ThreadOut AI from the full thread. May miss nuance — read the thread below.

  1. #1

    🚨 BREAKTHROUGH: A 3-year-old boy in Houston was just declared cancer-free after a revolutionary new treatment. He had aggressive liver cancer that stopped responding to chemo. Doctors used his own cells to hunt down the tumor. One year later? No cancer detected.🧵

  2. #2

    The child was fighting hepatoblastoma, the most common pediatric liver cancer. He had a large tumor and it had spread to his lungs. He went through 3 rounds of chemotherapy and surgery, but the cancer kept coming back. He was running out of options. That’s when he entered the CARE study at Baylor & Texas Children’s.

  3. #3

    This isn’t standard chemo. This is Personalized Immunotherapy. Scientists took the child’s own T-cells (his immune system’s soldiers) and genetically engineered them in a lab. They armed these cells with a specific receptor (GPC3-CAR) to find the cancer, plus a turbo-boost (IL15/IL21) to make them stronger.

  4. #4

    The process was surprisingly smooth. They infused these super-charged cells back into the boy just twice, 8 weeks apart. Incredibly, this was done entirely in an outpatient setting. No grueling hospital stays. After the first infusion, the tumors shrank. After the second? They vanished.

  5. #5

    Dr. David Steffin reported that imaging showed complete resolution of the metastatic disease. Even better: The child experienced zero dose-limiting toxicities or cytokine release syndrome (which are dangerous side effects common in other immunotherapies). One year later, he is still cancer-free.

  6. #6

    Do Follow us for evidence-based scientific explanations and insights.

  7. #7

    bcm.edu/news/care-stud…